CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

This study is testing a new type of cancer treatment called CAR-NK cell therapy (CL-NK-003) for people with advanced or recurrent pancreatic cancer. CAR-NK cells are immune cells that have been engineered in a laboratory to recognise and attack cancer cells. **You may be eligible if...** - You are between 18 and 75 years old - You have locally advanced, metastatic, or recurrent pancreatic cancer - Your tumor shows a specific protein (eGR1) detected on at least 40% of cancer cells - Standard treatments have failed, were not tolerated, or were declined - You have at least one measurable area of cancer - You are in reasonably good health (ECOG performance status 0–2) - Your life expectancy is more than 12 weeks **You may NOT be eligible if...** - Your tumor does not express the eGR1 protein at the required level - You have received anti-cancer treatment within the past 4 weeks - Your blood counts or organ function are below the required thresholds Talk to your doctor to see if this trial is right for you.